Anna Latorre
Anna Latorre
Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology
Dirección de correo verificada de
Citado por
Citado por
Abnormal salivary total and oligomeric alpha-synuclein in Parkinson’s disease
G Vivacqua, A Latorre, A Suppa, M Nardi, S Pietracupa, R Mancinelli, ...
PloS one 11 (3), e0151156, 2016
Poor self-awareness of levodopa-induced dyskinesias in Parkinson's disease: clinical features and mechanisms
S Pietracupa, A Fasano, G Fabbrini, M Sarchioto, M Bloise, A Latorre, ...
Parkinsonism & Related Disorders 19 (11), 1004-1008, 2013
Fatigue in Parkinson's disease: motor or non-motor symptom?
G Fabbrini, A Latorre, A Suppa, M Bloise, M Frontoni, A Berardelli
Parkinsonism & related disorders 19 (2), 148-152, 2013
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up
M Sensi, G Cossu, F Mancini, M Pilleri, M Zibetti, N Modugno, R Quatrale, ...
Parkinsonism & related disorders 38, 90-92, 2017
Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study
A Tessitore, P Marano, N Modugno, FE Pontieri, N Tambasco, M Canesi, ...
Journal of neurology 265 (5), 1124-1137, 2018
The use of transcranial magnetic stimulation as a treatment for movement disorders: a critical review
A Latorre, L Rocchi, A Berardelli, KP Bhatia, JC Rothwell
Movement Disorders 34 (6), 769-782, 2019
Adherence to anti-Parkinson drug therapy in the "REASON" sample of Italian patients with Parkinson's disease: the linguistic validation of the Italian version of the "Morisky …
CR Fabbrini G, Abbruzzese G, Barone P, Antonini A, Tinazzi M, Castegnaro G ...
Neurological Science 34 (11), 2015-22, 2013
The interindividual variability of transcranial magnetic stimulation effects: implications for diagnostic use in movement disorders
A Latorre, L Rocchi, A Berardelli, KP Bhatia, JC Rothwell
Movement Disorders 34 (7), 936-949, 2019
Pathophysiology of pain and fatigue in Parkinson's disease
A Berardelli, A Conte, G Fabbrini, M Bologna, A Latorre, L Rocchi, ...
Parkinsonism & related disorders 18, S226-S228, 2012
Non-invasive suppression of essential tremor via phase-locked disruption of its temporal coherence
SR Schreglmann, D Wang, RL Peach, J Li, X Zhang, A Latorre, E Rhodes, ...
Nature communications 12 (1), 1-15, 2021
Unravelling the enigma of cortical tremor and other forms of cortical myoclonus
A Latorre, L Rocchi, F Magrinelli, E Mulroy, A Berardelli, JC Rothwell, ...
Brain 143 (9), 2653-2663, 2020
Primary motor cortex long‐term plasticity in multiple system atrophy
A Suppa, L Marsili, F Di Stasio, A Latorre, AK Parvez, C Colosimo, ...
Movement Disorders 29 (1), 97-104, 2014
Impaired automatic but intact volitional inhibition in primary tic disorders
V Rawji, S Modi, A Latorre, L Rocchi, L Hockey, K Bhatia, E Joyce, ...
Brain 143 (3), 906-919, 2020
Ten‐year reflections on the neurophysiological abnormalities of focal dystonias in humans
A Conte, L Rocchi, A Latorre, D Belvisi, JC Rothwell, A Berardelli
Movement Disorders 34 (11), 1616-1628, 2019
Twenty years on: Myoclonus‐dystonia and ε‐sarcoglycan—neurodevelopment, channel, and signaling dysfunction
E Menozzi, B Balint, A Latorre, EM Valente, JC Rothwell, KP Bhatia
Movement Disorders 34 (11), 1588-1601, 2019
Motor cortical excitability during voluntary inhibition of involuntary tic movements
C Ganos, L Rocchi, A Latorre, L Hockey, C Palmer, EM Joyce, KP Bhatia, ...
Movement disorders 33 (11), 1804-1809, 2018
Are studies of motor cortex plasticity relevant in human patients with Parkinson’s disease?
M Bologna, A Suppa, A Conte, A Latorre, JC Rothwell, A Berardelli
Clinical Neurophysiology 127 (1), 50-59, 2016
Parkinsonian patients and poor awareness of dyskinesias
S Pietracupa, A Latorre, A Berardelli, G Fabbrini
Frontiers in Neurology 5, 32, 2014
Reappraisal of cortical myoclonus: A retrospective study of clinical neurophysiology
A Latorre, L Rocchi, A Berardelli, JC Rothwell, KP Bhatia, C Cordivari
Movement Disorders 33 (2), 339-341, 2018
Reasons driving treatment modification in Parkinson's disease: results from the cross-sectional phase of the REASON study
BP Tinazzi M, Abbruzzese G, Antonini A, Ceravolo R, Fabbrini G, Lessi P, ...
Parkinsonism and Related Disorderd 19 (12), 1130-5, 2013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20